documents: FDA-2024-N-2980-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-N-2980-0001 FDA FDA-2024-N-2980 Evaluating the Immunogenicity Risk of Host Cell Proteins in Follow-On Recombinant Peptide Products; Establishment of a Public Docket; Request for Information and Comments Notice Request for Comments 2024-07-25T04:00:00Z 2024 7 2024-07-25T04:00:00Z 2025-03-04T04:59:59Z 2025-03-05T02:00:37Z 2024-16356 0 0 0900006486605081

Links from other tables